Viagra vs Cialis: How the Two ED Pills Compare

Written by Empire Medical Training Editorial Team

Medically reviewed by Betsy Greenleaf, DO Board-Certified OB/GYN & Urogynecologist; Empire Director of Anti-Aging

Updated June 2026 ·11 min read

Viagra and Cialis are the two best-known oral medications for erectile dysfunction, and they are routinely compared as if they were rivals. In clinical reality they are close relatives. Both are PDE5 inhibitors — the same class, the same biochemical target, the same fundamental effect on blood flow. The meaningful differences between them are practical rather than mechanistic, and they come down almost entirely to how long the drug works and how it is dosed.

This page is written for clinicians who want an accurate, plain-spoken comparison they can use in patient conversations. It is clinical education, not medical advice, and nothing here should be read as a treatment recommendation, dosing protocol, or substitute for current FDA labeling.

The quick answer

If a patient or colleague wants the comparison in one breath: Viagra and Cialis are both PDE5 inhibitors, so they work the same way — the difference is timing. Sildenafil (Viagra) is the shorter-acting, on-demand option, taken a short while before activity and working for a few hours. Tadalafil (Cialis) is the longer-acting option, with an effect window measured in tens of hours rather than a few, and it can also be taken as a small daily dose so a patient is not timing each pill to a specific occasion.

That single distinction — a tight, on-demand window versus a long, more spontaneous one — drives most of the practical decision-making. One critical caveat applies to both, and it is the same caveat that applies to every drug in this class: a PDE5 inhibitor improves the plumbing, not the desire. As Dr. Betsy Greenleaf puts it in Empire's course, without brain stimulation, all the Viagra in the world will not function. These pills facilitate an erection in response to arousal; they do not create arousal. Neither one is a “desire pill,” and patients who expect that are reliably disappointed.

How each one works

Because Viagra and Cialis share a mechanism, understanding one is understanding both. During sexual stimulation, nerves and endothelium in the penis release nitric oxide, which triggers production of cyclic GMP (cGMP). Cyclic GMP relaxes the smooth muscle of the penile arteries and sinusoids, blood flows in, the tissue engorges, and the resulting pressure compresses the veins that would otherwise drain it — trapping blood and producing a firm erection.

The enzyme phosphodiesterase type 5 (PDE5) is what naturally breaks cGMP back down, ending the response. Both Viagra and Cialis are PDE5 inhibitors: they block that enzyme, so cGMP accumulates and its vasodilating effect is sustained. Crucially, this only amplifies a signal that sexual stimulation has already started. The drugs do not generate the nitric oxide cascade on their own; they prolong it. That is exactly why arousal is still required, and why the same molecule helps in pulmonary hypertension, where the target is relaxing blood vessels in the lungs. For the full biochemistry shared across this entire drug class, see our dedicated guide to PDE5 inhibitors.

So if the mechanism is identical, why do the two drugs behave so differently in practice? The answer is not what they do but how long they keep doing it — a matter of how each molecule is absorbed and cleared.

Onset and duration

This is the headline difference and the reason most patients ultimately have a preference. Onset is broadly similar for the two: taken on demand, both typically begin working within roughly 30 to 60 minutes. Speed is not where they meaningfully diverge.

Duration is where they separate sharply. Viagra (sildenafil) has a relatively short effective window — on the order of four to six hours — which makes it a clean fit for an anticipated, time-bounded occasion. Cialis (tadalafil) is the long-acting agent, with a single dose able to support erectile function for up to about 36 hours. That extended window is why tadalafil is sometimes nicknamed the “weekend pill”: it decouples the medication from the moment, allowing for far more spontaneity over a day or two without re-dosing around the clock.

The clinical translation is straightforward. A patient who wants a predictable pill for a specific evening may prefer the shorter, on-demand profile. A patient who finds scheduling intimacy around a pill intrusive — or who simply values spontaneity — often gravitates to the longer window. Neither profile is “better” in the abstract; the better choice is the one that matches how the patient actually lives.

Food effects and the daily-dosing option

Two further practical differences follow from the pharmacology. The first is food sensitivity. Viagra absorption can be slowed by a heavy, high-fat meal, which delays its onset; for that reason it is frequently taken on an empty stomach for the most predictable effect. Cialis is generally not meaningfully affected by food and can be taken with or without a meal — one more way its profile favors flexibility over precise timing.

The second is the daily-dose option that is unique to tadalafil. In addition to on-demand use, Cialis is available as a low-dose daily tablet. Taken every day, it keeps a steady level of drug on board so the patient is never timing a dose to an occasion at all — intimacy can simply happen. This daily formulation also connects to tadalafil's second approved use: it carries an FDA indication for the lower-urinary-tract symptoms of benign prostatic hyperplasia (BPH). For an older man with both mild ED and bothersome BPH symptoms, a single daily medication that addresses both is a genuinely elegant option — a clinical efficiency Viagra does not offer.

Viagra vs Cialis at a glance

The table below summarizes the practical distinctions discussed above. The values are conceptual reference points for clinical orientation, not dosing instructions — specific doses, titration, and eligibility belong to current FDA labeling and individual clinical judgment.

Side effects and cautions

Because they share a mechanism, Viagra and Cialis share most of their class side effects: headache, facial flushing, nasal congestion, and indigestion are the common, generally mild and transient ones. There are minor differences in emphasis — sildenafil is the agent more associated with a temporary bluish tinge to vision, while tadalafil's longer half-life is more associated with back or muscle ache — but the overall safety footprint is similar.

The single most important safety point applies equally to both drugs and is non-negotiable: PDE5 inhibitors are absolutely contraindicated with nitrates. Nitrate medications (such as nitroglycerin and related compounds used for chest pain) and PDE5 inhibitors both lower blood pressure through the same nitric-oxide / cGMP pathway, and combining them can cause a profound, dangerous drop in blood pressure. Caution also applies with alpha-blockers and other antihypertensives, and in patients with significant cardiovascular disease. This last point matters more than it first appears, because erectile dysfunction is frequently a cardiovascular warning sign — in Dr. Greenleaf's framing, the canary in the coal mine — so the man asking for an ED pill may be the same man who needs a cardiac evaluation. Screening for nitrate use and cardiovascular risk is a baseline step before either drug is prescribed.

How providers choose between them

With efficacy broadly comparable across the class, choosing between Viagra and Cialis is less about which drug is “stronger” and more about matching the profile to the patient. A few practical questions usually settle it:

• How does the patient want to use it? A planned, time-bounded occasion suits the short on-demand profile; a desire for spontaneity over a day or two favors the long-acting agent.
• Does timing around meals matter? A patient who dislikes dosing on an empty stomach may do better with the food-insensitive option.
• On-demand or daily? Some patients strongly prefer never thinking about timing at all, which points toward the daily tadalafil option.
• Are there coexisting BPH symptoms? An older patient with both ED and bothersome lower-urinary-tract symptoms may be well served by a single medication that addresses both.
• What does tolerability and response show? If one agent causes a bothersome side effect or underperforms, switching within the class is often the next reasonable step.

Two points anchor every one of these conversations. First, the evaluation comes before the prescription: ED is a symptom, and the responsible approach — covered in our erectile dysfunction overview — is to look for underlying vascular, hormonal, neurologic, and psychological contributors rather than reflexively reaching for a pill. Second, when an oral agent is not enough, the toolkit does not end there. Patients who do not respond to PDE5 inhibitors may be candidates for other modalities — and a centrally acting option such as the melanocortin peptide PT-141 works on desire and arousal in the brain rather than on blood flow, a fundamentally different lever for the patient whose problem is not purely vascular. Hormonal contributors are worth screening too, since low testosterone can underlie ED; see our overview of hormone replacement therapy.

Training to prescribe PDE5 inhibitors competently

Prescribing Viagra or Cialis well is more than writing a script. It requires understanding the shared mechanism, screening for the nitrate contraindication and cardiovascular risk, matching the agent to how the patient actually lives, and knowing what to do when a PDE5 inhibitor is not enough. That clinical judgment is exactly what structured training delivers.